meniere’s disease
Otonomy’s OTIVIDEX ear medicine falls short in Phase III study
February 23, 2021Manufacturing and Production meniere's disease, otividex, otonomy
Otonomy’s OTIVIDEX treatment for Meniere’s disease has failed to meet its primary endpoint in its Phase III trial, the company …
Latest content
Highlighting the value of lab research for healthcare innovation
November 2, 2026
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
